1. Aebischer P, Schluep M, Deglon N, Joseph JM, Hirt L, Heyd B, Goddard M, Hammang JP, Zurn AD, Kato AC, Regli F, Baetge EE (1996) Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat Med 2:696–699
2. Aoi M, Date I, Tomita S, Ohmoto T (2000) GDNF induces recovery of thenigrostriatal dopaminergic system in the rat brain following intracerebroventricular or intraparenchymal administration. Acta Neurochir (Wien) 142:805–810
3. Barzilai A, Melamed E (2003) Molecular mechanisms of selective dopaminergicneuronal death in Parkinson's disease. Trends Mol Med 9:126–132
4. Barzilai A, Zilkha-Falb R, Daily D, Stern N, Offen D, Ziv I, Melamed E, Shirvan A (2000) The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity. J Neural Transm Suppl 60:59–76
5. Behrstock S, Svendsen CN (2004) Combining growth factors, stem cells, and genetherapy for the aging brain. Ann NY Acad Sci 1019:5–14